Early Endoscopy for Acute GI Bleeds Tied to Better Outcomes

Patients with acute upper gastrointestinal (GI) bleeding, especially those with non-variceal bleeding, tended to have the best outcomes if they received an early therapeutic endoscopy (between 6 to 24 hours after admission), a retrospective study of Hong Kong hospital data found.

In the analysis of more than 6,000 patients with acute upper GI bleeds, urgent endoscopy (6 hours or less from the time of admission) was associated with higher 30-day rates of all-cause mortality, intensive care unit (ICU) admission, and repeat endoscopy versus early endoscopy, reported Joseph Sung, MD, PhD, of the Nanyang Technological University in Singapore, and colleagues:

  • All-cause mortality: adjusted hazard ratio (aHR) 1.43 (95% CI 1.24-1.65, P
  • ICU admission: aHR 1.40 (95% CI 1.18-1.67, P
  • Repeat endoscopies: aHR 1.22 (95% CI 1.11-1.33, P

Receiving a late endoscopy (between 24 to 48 hours from admission) was also associated with greater 30-day mortality compared to the early group (HR 1.25, 95% CI 1.08-1.45, P=0.003) but a lower risk for ICU admission (HR 0.72, 95% CI 0.58-0.88, P=0.002), according to the findings in Gut.

More in-hospital deaths occurred in both the urgent (6.2%) and late (5.8%) groups, as compared to the early group (4.3%; P

“When also taking into account bleeding etiology, the results were only consistent with non-variceal bleeding,” the authors noted. “For variceal bleeding, only late endoscopy was associated with worse outcomes, with higher rates of repeated endoscopy and ICU admission.”

“Results of this study suggest that most AUGIB patients need not be rushed to endoscopy immediately,” Sung and colleagues wrote in their conclusion. “Rather, active resuscitation and optimal medical treatment should be initiated as appropriate, then with endoscopy performed within 24 hours of presentation.”

Reached for comment, Jacques Van Dam, MD, PhD, of the University of Southern California in Los Angeles, called the findings “critically important,” but told MedPage Today that the poorer outcomes seen among patients in the urgent group “could be explained by the fact that they were at higher risk.”

“Patients who underwent urgent (≤6 hours) endoscopy may have been deemed more seriously ill by the physicians assessing them,” said Van Dam, who was not involved in the study. “If so, you might expect that they would not do as well compared with those patients thought to be stable enough to wait for their procedure (6-24 hours).”

Current guidelines by many organizations, including the American College of Gastroenterology, recommend an endoscopy for patients with acute upper GI bleeding within 24 hours of diagnosis, but data on more optimal timing are lacking, the authors noted.

The findings build upon those from a randomized trial the group conducted, which showed no benefit for urgent endoscopies in patients with acute upper GI bleeding at high risk for further bleeding events or death.

For their current study, Sung and colleagues evaluated territory-wide data on 6,474 adults with acute upper GI bleeding treated at public hospitals in Hong Kong from 2013 to 2019.

Esophagogastroduodenoscopy within 2 days of admission was among the inclusion criteria. A total of 3,865 patients received an early endoscopy (>6 to ≤24 hours), 1,601 had a late endoscopy (>24 to ≤48 hours), while 1,008 patients received an urgent endoscopy (≤6 hours). The early group had an average time of 15.6 hours to endoscopy, compared with an average time of 32.2 hours and 4.08 hours for the late and urgent groups, respectively.

Thirty-day all-cause mortality was the study’s primary outcome, and bleeding severity was defined by the Glasgow-Blatchford score (GBS).

Inverse probability of treatment weighting was used to balance baseline characteristics, the authors noted. Participants were mostly men (67-72% across groups), with an average age of 66-70 years, and mean modified GBS scores of 7.91-9.37. Common patient comorbidities included cancer, diabetes, and cardiac disease. While most had no significant comorbidities, 9.5% had Charlson Comorbidity index scores of 3 or greater.

The vast majority of the GI bleeds were consistent with peptic ulcer (88-91%) etiology, and most patients had non-variceal bleeding (95.6%).

The analysis had several limitations, the researchers acknowledged, including that residual confounding may have occurred and that a significant amount of patient vital sign data was unaccounted for.

Last Updated September 23, 2021

  • author['full_name']

    Zaina Hamza is a staff writer for MedPage Today, covering Gastroenterology and Infectious disease. She is based in Chicago.

Disclosures

Sung and coauthors reported no conflicts of interest.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Jennifer Aniston Made This Workout Swap After Years of Hard Cardio ‘Pounded’ Her Body thumbnail

Jennifer Aniston Made This Workout Swap After Years of Hard Cardio ‘Pounded’ Her Body

For years, Jennifer Aniston felt like she had to do high-intensity cardio workouts in order to feel fit.“It was like run, run, run, run, run, boxing, boxing, boxing, boxing,” the actor tells SELF. “I really just pounded my body.” Then she learned about functional fitness, a type of exercise that prepares your body to better handle the movements required in everyday
Read More
Pfizer vaccine for kids may not be available until November thumbnail

Pfizer vaccine for kids may not be available until November

In this Jan. 22, 2021, file photo, a certified medical assistant prepares doses of the Pfizer COVID-19 vaccine at a vaccination center at the University of Nevada, Las Vegas. With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they're confident both seniors and other vulnerable Americans seeking booster shots and…
Read More
Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer thumbnail

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Oncology/Hematology > Lung Cancer — Half of patients responded, but editorialists call for new directions in therapy development by Charles Bankhead, Senior Editor, MedPage Today June 11, 2024 A China-developed KRAS inhibitor led to objective responses in half of patients with previously treated KRAS-mutant non-small cell lung cancer (NSCLC), a prospective non-randomized trial showed. Overall
Read More
Salmonella behind a quarter of EU outbreaks in 2020 with 20,000 sickened thumbnail

Salmonella behind a quarter of EU outbreaks in 2020 with 20,000 sickened

Salmonella caused almost a quarter of foodborne outbreaks in Europe in 2020, according to a report. The main sources of salmonellosis outbreaks were eggs, egg products and pig meat. Norovirus in crustaceans, shellfish, mollusks and products containing them and Listeria monocytogenes in fish and fish products were other agents and food pairs of concern. A total of 3,086 foodborne…
Read More
Index Of News
Total
0
Share